» Articles » PMID: 34068971

Tissue Engineering Through 3D Bioprinting to Recreate and Study Bone Disease

Overview
Journal Biomedicines
Date 2021 Jun 2
PMID 34068971
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The applications of 3D bioprinting are becoming more commonplace. Since the advent of tissue engineering, bone has received much attention for the ability to engineer normal bone for tissue engraftment or replacement. While there are still debates on what materials comprise the most durable and natural replacement of normal tissue, little attention is given to recreating diseased states within the bone. With a better understanding of the cellular pathophysiology associated with the more common bone diseases, these diseases can be scaled down to a more throughput way to test therapies that can reverse the cellular pathophysiology. In this review, we will discuss the potential of 3D bioprinting of bone tissue in the following disease states: osteoporosis, Paget's disease, heterotopic ossification, osteosarcoma, osteogenesis imperfecta, and rickets disease. The development of these 3D bioprinted models will allow for the advancement of novel therapy testing resulting in possible relief to these chronic diseases.

Citing Articles

Microenvironment-targeted strategy steers advanced bone regeneration.

Hao S, Wang M, Yin Z, Jing Y, Bai L, Su J Mater Today Bio. 2023; 22:100741.

PMID: 37576867 PMC: 10413201. DOI: 10.1016/j.mtbio.2023.100741.


Why Animal Experiments Are Still Indispensable in Bone Research: A Statement by the European Calcified Tissue Society.

Stein M, Elefteriou F, Busse B, Fiedler I, Kwon R, Farrell E J Bone Miner Res. 2023; 38(8):1045-1061.

PMID: 37314012 PMC: 10962000. DOI: 10.1002/jbmr.4868.


Three-Dimensional Bioprinting Applications for Bone Tissue Engineering.

Maresca J, DeMel D, Wagner G, Haase C, Geibel J Cells. 2023; 12(9).

PMID: 37174630 PMC: 10177443. DOI: 10.3390/cells12091230.


Applications of Biotechnology to the Craniofacial Complex: A Critical Review.

Tsolakis I, Christopoulou I, Papadopoulou E, Papaioannou W, Alexiou K, Lyros I Bioengineering (Basel). 2022; 9(11).

PMID: 36354551 PMC: 9687908. DOI: 10.3390/bioengineering9110640.


Electrospun Biomimetic Nanofibrous Scaffolds: A Promising Prospect for Bone Tissue Engineering and Regenerative Medicine.

Anjum S, Rahman F, Pandey P, Arya D, Alam M, Rajinikanth P Int J Mol Sci. 2022; 23(16).

PMID: 36012473 PMC: 9408902. DOI: 10.3390/ijms23169206.


References
1.
Singer F . Paget disease: when to treat and when not to treat. Nat Rev Rheumatol. 2009; 5(9):483-9. DOI: 10.1038/nrrheum.2009.149. View

2.
Daly A, Pitacco P, Nulty J, Cunniffe G, Kelly D . 3D printed microchannel networks to direct vascularisation during endochondral bone repair. Biomaterials. 2018; 162:34-46. DOI: 10.1016/j.biomaterials.2018.01.057. View

3.
Hayashi K, Kishida R, Tsuchiya A, Ishikawa K . Granular Honeycombs Composed of Carbonate Apatite, Hydroxyapatite, and β-Tricalcium Phosphate as Bone Graft Substitutes: Effects of Composition on Bone Formation and Maturation. ACS Appl Bio Mater. 2022; 3(3):1787-1795. DOI: 10.1021/acsabm.0c00060. View

4.
Hoyer-Kuhn H, Netzer C, Semler O . Osteogenesis imperfecta: pathophysiology and treatment. Wien Med Wochenschr. 2015; 165(13-14):278-84. DOI: 10.1007/s10354-015-0361-x. View

5.
Lu J, Song G, Tang Q, Zou C, Han F, Zhao Z . IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling. J Clin Invest. 2015; 125(5):1839-56. PMC: 4463198. DOI: 10.1172/JCI78437. View